CSU.TO
Constellation Software
Public Equity — Direct
Watchlist Score
50.0
/ 50
Buy
- CSU is the permanent compounder for vertical-market software — it deploys free cash flow at 20%+ IRR into niche software acquisitions no larger fund can touch.
- Why now: the VMS acquisition universe is expanding internationally (Europe, LATAM) as founders age out and no other buyer has the local knowledge and patience CSU has.
- What changes the world's view: if CSU demonstrates 30%+ FCF growth through the Lumine spin-off structure, the market re-rates from 'boring acquirer' to 'Berkshire of software'.
Moat
Extremely wide: switching costs in niche vertical-market software are near-absolute. Customers use CSU's products to run their business (libraries, golf courses, utilities). Replacement costs 3–5x the subscription value.
Unit Economics
SaaS-like recurring revenue ~70%. Organic growth 3–5% per annum; acquisition-led growth compounds total revenue 20%+. Gross margins ~65%. FCF conversion 90%+ of net income.
Capital Allocation
50-year track record of capital allocation. Mark Leonard personally reinvests. Returns on acquired capital average 20–25% IRR. No buybacks (FCF fully redeployed). No dividends until 2021 spin experiment.
Management
Mark Leonard is the controlling mind. Succession risk is real but partially mitigated by decentralized GM structure (each portfolio company runs autonomously) and strong operator bench inside each vertical.
Current Multiple
P/FCF ~30x trailing. 10-year average ~35x. Below the 5-year average of 40x. EV/EBIT ~25x vs. 30x historical.
Method
Owner-Earnings Yield
CMA Expected Return (sleeve)
7% (public equity sleeve CMA, 60/40 blended)
Prob-Weighted IRR (3yr)
16.8% p.a.
Owner earnings ~$130/share (USD), price $3,800 CAD (~$2,780 USD). Owner-earnings yield ~4.7%. Add organic growth 4–5% + M&A deployment lift → total expected return 18–22%/year. Beats public equity CMA of 7% by 11–15 pts.
| Case |
3yr IRR |
Probability |
Weight |
| Bull |
+28.0% |
20.00%
|
5.6% |
| Base |
+18.0% |
60.00%
|
10.8% |
| Bear |
+2.0% |
20.00%
|
0.4% |
| Probability-Weighted Expected IRR |
16.8% |
Initial %
1.50%
of $5M portfolio
Initial $
$75,000
on $5M base
Max %
4.00%
full conviction size
Max $
$200,000
on $5M base
Sleeve context: Public Equity sleeve target is 40% of $5M = $2.0M.
Initial position of 1.50% ($75,000) represents
4% of sleeve capacity.
Max position of 4.00% ($200,000) represents
10% of sleeve.
- Mark Leonard steps back with no clear successor and decentralization fails
- M&A pipeline dries up — FCF piles up with no outlet above cost of capital
- Regulatory action forces restructuring of VMS acquisitions in EU
- Organic churn accelerates above 10% in any core vertical
- Key-person concentration: Mark Leonard remains the intellectual engine despite decentralization.
- Currency risk: priced in CAD, most reporting is USD-blended — translation effects can mask or flatter results.
- Premium valuation leaves no margin of safety if FCF growth slows to below 15%.
- Acquisition market competition: PE has noticed VMS. Multiples paid have crept up from 1.0x to 1.5x revenue in some verticals.
Section 09 — Decision & Next Step
Buy
CSU is the highest-conviction name on the watchlist. Size 1.5% initial, build to 4% max over 24 months as the business proves international M&A cadence. This anchors the public equity sleeve with a compounder and reduces index-beta risk.